Ignite Creation Date:
2025-12-24 @ 10:53 PM
Ignite Modification Date:
2025-12-30 @ 8:37 AM
Study NCT ID:
NCT00598169
Status:
COMPLETED
Last Update Posted:
2020-08-10
First Post:
2008-01-09
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Bortezomib, Ifosfamide, Carboplatin, and Etoposide, With or Without Rituximab, in Treating Patients With Relapsed or Refractory AIDS-Related Non-Hodgkin Lymphoma
Sponsor:
AIDS Malignancy Consortium
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2007-11
Start Date Type:
None
Primary Completion Date:
2014-10
Primary Completion Date Type:
ACTUAL
Completion Date:
2014-11
Completion Date Type:
ACTUAL
First Submit Date:
2008-01-09
First Submit QC Date:
None
Study First Post Date:
2008-01-18
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-08-07
Last Update Post Date:
2020-08-10
Last Update Post Date Type:
ACTUAL